ChangLing Lv
YinRui Li3
DingYu Wu- 1College of Pharmacy, Dali University, Dali, China
- 2Yunnan Provincial Key Laboratory of Entomological Biopharmaceutical R&D, Dali, China
- 3Department of Pharmacy, Mengzi People’s Hospital, Mengzi, China
A Corrigendum on
Metabonomic analysis of the anti-hepatic fibrosis effect of Ganlong capsules
by Lv C, Li Y, Ou L, Zhou J, Peng F and Wu D (2023). Front. Pharmacol. 14:1122118. doi: 10.3389/fphar.2023.1122118
In the published article, there was an error in Figures 3, 6, 9 as published. The reason for this is a mistake was made in the order of BPC pictures of different tissue samples. The corrected Figures 3, 6 and 9 and their captions appear below.
FIGURE 3. Representative BPC of rat liver tissue in positive and negative ion mode for each group.
FIGURE 6. Representative BPC of rat Serum in positive and negative ion mode for each group.
FIGURE 9. Representative BPC graph of rat urine in positive and negative ion mode for each group.
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Keywords: Ganlong capsule, hepatic fibrosis, CCl4, metabolomic analysis, LC-MS
Citation: Lv C, Li Y, Ou L, Zhou J, Peng F and Wu D (2023) Corrigendum: Metabonomic analysis of the anti-hepatic fibrosis effect of Ganlong capsules. Front. Pharmacol. 14:1231544. doi: 10.3389/fphar.2023.1231544
Received: 30 May 2023; Accepted: 04 July 2023;
Published: 07 July 2023.
Edited and reviewed by:
Shikai Yan, Shanghai Jiao Tong University, ChinaCopyright © 2023 Lv, Li, Ou, Zhou, Peng and Wu. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: DingYu Wu, fetoio@sina.com